(Q45080881)

9 December 2017

Role of proliferation in LAK cell development (English)

1 reference

9 December 2017

F J Ramsdell

1

1 reference

9 December 2017

H Shau

series ordinal

2

1 reference

9 December 2017

S H Golub

series ordinal

3

1 reference

9 December 2017

1 January 1988

1 reference

Cancer Immunology, Immunotherapy

9 December 2017

1 reference

9 December 2017

26

1 reference

9 December 2017

139-144

1 reference

9 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00205607

9 December 2017

0 references

cites work

Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow

1 reference

12 December 2020

Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.

1 reference

12 December 2020

The functional capacity of thymus subpopulations: limit-dilution analysis of all precursors of cytotoxic lymphocytes and of all T cells capable of proliferation in subpopulations separated by the use of peanut agglutinin

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

Precursor phenotype of lymphokine-activated killer cells in the mouse

1 reference

12 December 2020

Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.

1 reference

12 December 2020

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

12 December 2020

Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation

1 reference

12 December 2020

1 reference

12 December 2020

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

12 December 2020

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1 reference

12 December 2020

Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells

1 reference

12 December 2020

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

12 December 2020

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

12 December 2020

Suppression of human NK cell cytotoxicity by an MLC-Generated cell population

1 reference

12 December 2020

Generation of lymphokine-activated killer cell activity from human thymocytes

1 reference

12 December 2020

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

12 December 2020

Generation of lymphokine-activated killer cells does not require DNA synthesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205607

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference